Zhimei Liu Selected Research

Neoplasms (Cancer)

4/2019	The antagonism between apigenin and protoapigenone to the PDK-1 target in Macrothelypteris torresiana.
12/2018	Burden of renal angiomyolipomas associated with tuberous sclerosis complex: results of a patient and caregiver survey.
10/2015	An Indirect Comparison of Everolimus Versus Axitinib in US Patients With Advanced Renal Cell Carcinoma in Whom Prior Sunitinib Therapy Failed.
4/2015	Tuberous sclerosis complex: a survey of health care resource use and health burden.
5/2014	RY10-4 suppressed metastasis of MDA-MB-231 by stabilizing ECM and E-cadherin.
7/2013	Review of US Comparative Economic Evidence for Treatment of Metastatic Renal Cell Carcinoma after Failure of First-Line VEGF Inhibitor Therapy.
6/2013	Everolimus vs. temsirolimus for advanced renal cell carcinoma: use and use of resources in the US Oncology Network.
4/2013	United States-based practice patterns and resource utilization in advanced neuroendocrine tumor treatment.
8/2011	Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review.
1/2009	The economic value of primary prophylaxis using pegfilgrastim compared with filgrastim in patients with breast cancer in the UK.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhimei Liu Research Topics

Disease

16	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 07/2011
11	Neoplasms (Cancer) 04/2019 - 09/2007
10	Tuberous Sclerosis (Bourneville's Disease) 12/2018 - 08/2011
8	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 10/2015
6	Angiomyolipoma 12/2018 - 08/2015
6	Breast Neoplasms (Breast Cancer) 05/2014 - 08/2005
4	Inborn Genetic Diseases (Disease, Hereditary) 12/2018 - 08/2011
4	Stroke (Strokes) 10/2015 - 08/2005
4	Ovarian Neoplasms (Ovarian Cancer) 08/2007 - 08/2005
3	Brain Diseases (Brain Disorder) 02/2024 - 01/2019
3	Febrile Neutropenia 03/2009 - 09/2007
3	Coronary Disease (Coronary Heart Disease) 06/2007 - 08/2005
2	MELAS Syndrome (Syndrome, MELAS) 01/2022 - 01/2021
2	Disease Progression 01/2021 - 03/2013
2	Leigh Disease (Leigh's Disease) 01/2020 - 10/2015
2	Congenital myasthenic syndrome with episodic apnea 01/2019 - 10/2015
2	Chronic Renal Insufficiency 01/2017 - 09/2016
2	Hematuria 01/2017 - 09/2016
2	Renal Insufficiency (Renal Failure) 01/2017 - 09/2016
2	Neoplasm Metastasis (Metastasis) 11/2014 - 05/2014
2	Primitive Neuroectodermal Tumors (PNET) 04/2013 - 01/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2007 - 05/2007
2	Dementia (Dementias) 08/2007 - 05/2007
2	Osteoporosis 06/2007 - 05/2007
1	Brain Edema (Cerebral Edema) 02/2024
1	Leukoencephalopathies 02/2024
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2024
1	Multiple Sclerosis 01/2024
1	Inflammation (Inflammations) 03/2023
1	Brain Ischemia (Cerebral Ischemia) 10/2022
1	Reperfusion Injury 10/2022
1	Seizures (Absence Seizure) 01/2022
1	Microcephaly 01/2022
1	Autism Spectrum Disorder 12/2021
1	Asthma (Bronchial Asthma) 10/2021
1	Beta-Hydroxyisobutyryl CoA Deacylase Deficiency 01/2021
1	Optic Atrophy 01/2021
1	Vision Disorders (Hemeralopia) 01/2021
1	Dystonia (Limb Dystonia) 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019
1	Vomiting 01/2019
1	Infections 01/2019
1	Apnea 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 01/2019

Drug/Important Bio-Agent (IBA)

13	Everolimus FDA Link 04/2016 - 07/2011
10	trans-sodium crocetinate (crocetin)IBA 12/2018 - 08/2011
7	Tyrosine Kinase InhibitorsIBA 01/2017 - 07/2013
6	Sunitinib (Sutent)FDA Link 10/2015 - 07/2011
5	Axitinib (AG 013736)IBA 01/2016 - 07/2013
5	TOR Serine-Threonine KinasesIBA 01/2016 - 08/2011
4	Mitochondrial DNA (mtDNA)IBA 01/2022 - 10/2015
4	Sorafenib (BAY 43-9006)FDA Link 03/2015 - 07/2011
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2020
3	temsirolimus FDA Link 11/2014 - 06/2013
3	pegfilgrastim (Neulasta)FDA Link 03/2009 - 09/2007
2	Pyruvic Acid (Pyruvate)IBA 01/2022 - 02/2019
2	protoapigenoneIBA 04/2019 - 05/2014
2	MTOR InhibitorsIBA 11/2014 - 10/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 07/2013
2	Filgrastim (Neupogen)FDA Link 01/2009 - 09/2007
2	Hormones (Hormone)IBA 06/2007 - 05/2007
1	Hydro-Lyases (Dehydratases)IBA 02/2024
1	NucleotidesIBA 02/2024
1	Niacinamide (Nicotinamide)FDA LinkGeneric 02/2024
1	NAD (NADH)IBA 02/2024
1	EnzymesIBA 02/2024
1	Alemtuzumab (Campath)FDA Link 01/2024
1	CalciumIBA 03/2023
1	NADPH Oxidase 4IBA 10/2022
1	Glucose (Dextrose)FDA LinkGeneric 10/2022
1	Oxygen (Dioxygen)IBA 10/2022
1	cysteinyl-tRNA synthetaseIBA 03/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	mitocurcuminIBA 01/2022
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2022
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 12/2021
1	Thioctic Acid (Lipoic Acid)IBA 01/2021
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Leu Transfer RNAIBA 01/2021
1	Factor VII (Proconvertin)IBA 01/2021
1	Amino Acids FDA Link 01/2021
1	3-hydroxyisobutyryl-CoA hydrolaseIBA 01/2021
1	Enoyl-CoA HydrataseIBA 01/2020
1	Valine (L-Valine)FDA Link 01/2020
1	ApigeninIBA 04/2019
1	AcidsIBA 02/2019
1	SodiumIBA 02/2019
1	Taurine FDA Link 02/2019
1	ferrous citrate FDA Link 02/2019
1	Dynamin IIBA 01/2019
1	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 01/2019
1	GTP Phosphohydrolases (GTPases)IBA 01/2019

Therapy/Procedure

18	Therapeutics 01/2017 - 06/2007
4	Drug Therapy (Chemotherapy) 03/2013 - 09/2007
4	Ovariectomy (Oophorectomy) 08/2007 - 08/2005
3	Hysterectomy 08/2007 - 08/2005
2	Nephrectomy 01/2017 - 08/2015
1	Aftercare (After-Treatment) 01/2024
1	Cupping Therapy 10/2021